Development of adjuvant for effective oral vaccine application |
Kim, Sae-Hae
(Division of Biological Sciences, Chonbuk National University)
Seo, Ki-Weon (Division of Biological Sciences, Chonbuk National University) Kim, Ju (Jeonju Biomaterials Institute) Jang, Yong-Suk (Division of Biological Sciences, Chonbuk National University) |
1 | Duc M, Johansen FE, Corthesy B. (2010) Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors. J Biol Chem 285:953-960 DOI |
2 | Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K (2010) Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 28:243-273 DOI |
3 | Fievez V, Plapied L, des Rieux A, Pourcelle V, Freichels H, Wascotte V, Vanderhaeghen ML, Jerome C, Vanderplasschen A, Marchand-Brynaert J, Schneider YJ, Preat V (2009) Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. Eur J Pharm Biopharm 73:16-24 DOI |
4 | Gebert A, Rothkotter HJ, Pabst R (1996) M cells in Peyer’s patches of the intestine. Int Rev Cytol 167:91-159 DOI |
5 | Hase K, Kawano K, Nochi T, Pontes GS, Fukuda S, Ebisawa M, Kadokura K, Tobe T, Fujimura Y, Kawano S, Yabashi A, Waguri S, Nakato G, Kimura S, Murakami T, Iimura M, Hamura K, Fukuoka S, Lowe AW, Itoh K, Kiyono H, Ohno H (2009) Uptake through glycoprotein 2 of FimH (+) bacteria by M cells initiates mucosal immune response. Nature 462:226-230 DOI |
6 | Abreu MT (2010) Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10:131-144 DOI |
7 | Bevan MJ (2004) Helping the CD8 (+) T-cell response. Nat Rev Immunol 4:595-602 DOI |
8 | Takahashi I, Nochi T, Yuki Y, Kiyono H (2009) New horizon of mucosal immunity and vaccines. Curr Opin Immunol 21:352-258 DOI |
9 | Tokuhara D, Yuki Y, Nochi T, Kodama T, Mejima M, Kurokawa S, Takahashi Y, Nanno M, Nakanishi U, Takaiwa F, Honda T, Kiyono H (2010) Secretory IgA- mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc Natl Acad Sci USA 107:8794-8799 DOI |
10 | Tomasi Jr TB, Tan EM, Solomon A, Prendergast RA (1965) Characteristics of an immune system common to certain external secretions. J Exp Med 121:101-124 DOI |
11 | Brandtzaeg P, Kiyono H, Pabst R, Russell MW (2008) Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 1:31-37 DOI ScienceOn |
12 | Blanco HM, Lacoste MG, Elicabe RJ, Di Genaro MS (2008) IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine. Vaccine 26:6497-6502 DOI |
13 | Brandtzaeg P (2009) Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70:505-515 DOI ScienceOn |
14 | Brandtzaeg P, Johansen FE (2005) Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev 206:32-63 DOI |
15 | Brayden DJ, Jepson MA, Baird AW (2005) Keynote review: intestinal Peyer’s patch M cells and oral vaccine targeting. Drug Discov Today 10:1145-1157 DOI |
16 | Cerutti A (2008) The regulation of IgA class switching. Nat Rev Immunol 8:421-434 DOI |
17 | Cerutti A, Rescigno M (2008) The biology of intestinal immunoglobulin A responses. Immunity 28:740-750 DOI |
18 | Chadwick S, Kriegel C, Amiji M (2010) Nanotechnology solutions for mucosal immunization. Adv Drug Deliv Rev 62:394-407 DOI |
19 | Tyrer PC, Ruth Foxwell A, Kyd JM, Otczyk DC, Cripps AW (2007) Receptor mediated targeting of M-cells. Vaccine 25:3204-3209 DOI |
20 | Tsuji NM, Kosaka A (2008) Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells. Trends Immunol 29:532-540 DOI ScienceOn |
21 | Wershil BK, Furuta GT (2008) 4. Gastrointestinal mucosal immunity. J Allergy Clin Immunol 121:S380-383 DOI |
22 | Wu Y, Wang X, Csencsits KL, Haddad A, Walters N, Pascual DW (2001) M cell-targeted DNA vaccination. Proc Natl Acad Sci USA 98:9318-9323 DOI |
23 | Nochi T, Yuki Y, Matsumura A, Mejima M, Terahara K, Kim DY, Fukuyama S, Iwatsuki-Horimoto K, Kawaoka Y, Kohda T, Kozaki S, Igarashi O, Kiyono H (2007) A novel M cellspecific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med 204:2789-2796 DOI ScienceOn |
24 | Parrott DM (1976) The gut as a lymphoid organ. Clin Gastroenterol 5:211-228 DOI |
25 | Plotkin SA (2005) Vaccines: past, present and future. Nat Med 11:S5-11 |
26 | Siebers A, Finlay BB (1996) M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol 4:22-29 DOI |
27 | Ragnarsson EG, Schoultz I, Gullberg E, Carlsson AH, Tafazoli F, Lerm M, Magnusson KE, Soderholm JD, Artursson P (2008) Yersinia pseudotuberculosis induces transcytosis of nanoparticles across human intestinal villus epithelium via invasindependent macropinocytosis. Lab Invest 88:1215-1226 DOI |
28 | Reed SG, Bertholet S, Coler RN, Friede M (2009) New horizons in adjuvants for vaccine development. Trends Immunol 30:23-32 DOI |
29 | Rynda A, Maddaloni M, Mierzejewska D, Ochoa-Reparaz J, Maslanka T, Crist K, Riccardi C, Barszczewska B, Fujihashi K, McGhee JR, Pascual DW (2008) Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma 1. J Immunol 180:5187-5200 DOI |
30 | Slutter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Preat V (2009) Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release 138:113-121 DOI |
31 | Sun JB, Czerkinsky C, Holmgren J (2010) Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 71:1-11 DOI |
32 | Man AL, Lodi F, Bertelli E, Regoli M, Pin C, Mulholland F, Satoskar AR, Taussig MJ, Nicoletti C (2008) Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. J Immunol 181:5673-5680 DOI |
33 | Marra A, Isberg RR (1997) Invasin-dependent and invasinindependent pathways for translocation of Yersinia pseudotuberculosis across the Peyer’s patch intestinal epithelium. Infect Immun 65:3412-3421 |
34 | Misumi S, Masuyama M, Takamune N, Nakayama D, Mitsumata R, Matsumoto H, Urata N, Takahashi Y, Muneoka A, Sukamoto T, Fukuzaki K, Shoji S (2009) Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer. J Immunol 182:6061-6070 DOI |
35 | McGhee JR, Kunisawa J, Kiyono H (2007) Gut lymphocyte migration: we are halfway ‘home’. Trends Immunol 28:150-153 DOI |
36 | Mestecky J, Nguyen H, Czerkinsky C, Kiyono H (2008) Oral immunization: an update. Curr Opin Gastroenterol 24:713-719 DOI ScienceOn |
37 | Mishra N, Goyal AK, Tiwari S, Paliwal R, Paliwal SR, Vaidya B, Mangal S, Gupta M, Dube D, Mehta A, Vyas SP (2010) Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat 20:661-679 DOI |
38 | Nochi T, Yuki Y, Katakai Y, Shibata H, Tokuhara D, Mejima M, Kurokawa S, Takahashi Y, Nakanishi U, Ono F, Mimuro H, Sasakawa C, Takaiwa F, Terao K, Kiyono H (2009) A rice-based oral cholera vaccine induces macaque- specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity. J Immunol 183:6538-6544 DOI |
39 | Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11:S45-53 DOI |
40 | Iwasaki A (2007) Mucosal dendritic cells. Annu Rev Immunol 25:381-418 DOI |
41 | Jepson MA, Clark MA, Hirst BH (2004) M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery. Adv Drug Deliv Rev 56:511-525 DOI |
42 | Keljo DJ, Hamilton JR (1983) Quantitative determination of macromolecular transport rate across intestinal Peyer’s patches. Am J Physiol 244:G637-644 |
43 | Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P (2009) Alpha-Cgalactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27:3766-3774 DOI |
44 | Kendall MA (2010) Needle-free vaccine injection. Handb Exp Pharmacol 193-219 |
45 | Kiyono H, Fukuyama S (2004) NALT- versus Peyer’s-patchmediated mucosal immunity. Nat Rev Immunol 4:699-710 DOI |
46 | Knoop KA, Kumar N, Butler BR, Sakthivel SK, Taylor RT, Nochi T, Akiba H, Yagita H, Kiyono H, Williams IR (2009) RANKL is necessary and sufficient to initiate development of antigen-sampling M cells in the intestinal epithelium. J Immunol 183:5738-5747 DOI |
47 | Kuolee R, Chen W (2008) M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv 5:693-702 DOI ScienceOn |
48 | Mach J, Hshieh T, Hsieh D, Grubbs N, Chervonsky A (2005) Development of intestinal M cells. Immunol Rev 206:177-189 DOI ScienceOn |
49 | Chen D, Endres RL, Erickson CA, Maa YF, Payne LG (2002) Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity. Vaccine 20:2671-2679 DOI |
50 | Chwalek M, Lalun N, Bobichon H, Ple K, Voutquenne-Nazabadioko L (2006) Structure-activity relationships of some hederagenin diglycosides: haemolysis, cytotoxicity and apoptosis induction. Biochim Biophys Acta 1760:1418-1427 DOI ScienceOn |
51 | Clark MA, Jepson MA (2003) Intestinal M cells and their role in bacterial infection. Int J Med Microbiol 293:17-39 DOI |